User:Mr. Ibrahem/Solriamfetol

Solriamfetol, sold under the brand name Sunosi, is a medication used to treat excessive sleepiness associated with narcolepsy and obstructive sleep apnea. It is taken by mouth.

Common side effects include headache, nausea, anxiety, and trouble sleeping. Other side effects may include increased blood pressure and abuse. It interacts with monoamine oxidase (MAO) inhibitors. Safety in pregnancy and breastfeeding is unclear. It is a norepinephrine–dopamine reuptake inhibitor (NDRI); though how it improves wakefulness is not entirely clear.

Solriamfetol was approved for medical use in the United States in 2019 and Europe in 2020. In the United States its costs about 690 USD per month as of 2021. In the United States it is a Schedule IV controlled substance.